NR1I3 and inflammatory bowel disease: Consistently, CAR activation accelerates intestinal mucosal healing both in vitro and in vivo, suggesting that CAR plays a role in the maintenance of intestinal mucosal integrity, while CAR dysfunction could contribute to the pathogenesis of inflammatory bowel diseases.